[HTML][HTML] Identifying new safety risk of human serum albumin: a retrospective study of real-world data

H Lu, Y Zhang, P Liu - Frontiers in Pharmacology, 2024 - frontiersin.org
Objective: To mine and analyze the adverse reaction signals of human serum albumin
(HSA) using the FDA adverse event reporting system (FAERS) database for the safe clinical …

Review of the rational use and adverse reactions to human serum albumin in the People's Republic of China

T Zhou, S Lu, X Liu, Y Zhang, F Xu - Patient preference and …, 2013 - Taylor & Francis
Human serum albumin (HSA) is an ideal natural colloid that has been widely used in clinical
practice for supplemental albumin or as a plasma substitute during therapeutic plasma …

An 8-Year Retrospective Review of Human Albumin Solution (HAS) Use August 2015 to March 2023; Guy's and St Thomas' NHS Foundation Trust (GSTFT)

A Tameez Ud Din, P Harrington, D Anicee, MS Yazdani… - Blood, 2023 - ashpublications.org
Background: HAS is widely used in clinical practice for a variety of haematological, renal,
neurological, respiratory and metabolic conditions. A United Kingdom shortage in 2015 …

[HTML][HTML] Concerning Chapter 5–Human Albumin; in Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives, Transfus Med Hemother …

A Farrugia - Transfusion Medicine and Hemotherapy, 2010 - ncbi.nlm.nih.gov
Therapy with Blood Components and Plasma Derivatives are provided generously and
freely in the December 2009 issue of TRANSFUSION MEDICINE AND HEMOTHERAPY. As …

Albumin: a comprehensive review and practical guideline for clinical use

F Abedi, B Zarei, S Elyasi - European Journal of Clinical Pharmacology, 2024 - Springer
Purpose Nowadays, it is largely accepted that albumin should not be used in
hypoalbuminemia or for nutritional purpose. The most discussed indication of albumin at …

Safety of human albumin—serious adverse events reported worldwide in 1998–2000

JL Vincent, MM Wilkes… - British journal of …, 2003 - academic.oup.com
Background. Previous pharmacovigilance studies have indicated a low rate of adverse
events in patients receiving human albumin. However, the incidence of adverse events is …

Impact of manufacturing improvements on clinical safety of albumin: Australian pharmacovigilance data for 1988–2005

Y Che, FJ Wilson, J Bertolini, P Schiff… - Critical Care and …, 2006 - Elsevier
Objective: To evaluate the impact of manufacturing improvements on the clinical safety of
human albumin solutions in Australia. Methods: This retrospective study examined the …

Expert consensus on the use of human serum albumin in adult cardiac surgery

F Xiang, F Huang, J Huang, X Li, N Dong… - Chinese Medical …, 2023 - mednexus.org
Albumin, which is a 65-kDa liver-synthesized protein, accounts for nearly 50% of total
plasma protein and contributes to approximately 80% of intravascular oncotic pressure …

A real-world data analysis of acetylsalicylic acid in FDA Adverse Event Reporting System (FAERS) database

B Zhao, X Zhang, M Chen, Y Wang - Expert opinion on drug …, 2023 - Taylor & Francis
ABSTRACT Background Acetylsalicylic acid (Aspirin), one of the oldest medicines, is widely
used in various clinical fields. However, numerous adverse events (AEs) have been …

[HTML][HTML] Human Albumin Infusion in Critically Ill and Perioperative Patients: Narrative Rapid Review of Meta-Analyses from the Last Five Years

CJ Wiedermann - Journal of Clinical Medicine, 2023 - mdpi.com
Background: Human albumin, a vital plasma protein with diverse molecular properties, has
garnered interest for its therapeutic potential in various diseases, including critical illnesses …